1 Citation (Scopus)
2 Downloads (Pure)

Abstract

It is increasingly important that regulatory agencies catalyse the translation of scientific and technological innovation into improved patient-centred health care. Here, we highlight the strategic goals of the European Medicines Agency to advance regulatory science and optimize the opportunities arising in areas such as cell and gene therapies, big data and artificial intelligence.

Original languageEnglish
Pages (from-to)403-404
Number of pages2
JournalNature Reviews Drug Discovery
Volume18
Issue number6
Early online date15 Apr 2019
DOIs
Publication statusPublished - 3 Jun 2019

Keywords

  • Drug discovery

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

The European Medicines Agency’s goals for regulatory science to 2025. / Hines, Philip; Guy, Richard; Humphreys, Anthony; Papaluca-Amati, Marisa.

In: Nature Reviews Drug Discovery, Vol. 18, No. 6, 03.06.2019, p. 403-404.

Research output: Contribution to journalComment/debate

Hines, Philip ; Guy, Richard ; Humphreys, Anthony ; Papaluca-Amati, Marisa. / The European Medicines Agency’s goals for regulatory science to 2025. In: Nature Reviews Drug Discovery. 2019 ; Vol. 18, No. 6. pp. 403-404.
@article{8b63a0e50fc84483bb941c63d6e59915,
title = "The European Medicines Agency’s goals for regulatory science to 2025",
abstract = "It is increasingly important that regulatory agencies catalyse the translation of scientific and technological innovation into improved patient-centred health care. Here, we highlight the strategic goals of the European Medicines Agency to advance regulatory science and optimize the opportunities arising in areas such as cell and gene therapies, big data and artificial intelligence.",
keywords = "Drug discovery",
author = "Philip Hines and Richard Guy and Anthony Humphreys and Marisa Papaluca-Amati",
year = "2019",
month = "6",
day = "3",
doi = "10.1038/d41573-019-00071-2",
language = "English",
volume = "18",
pages = "403--404",
journal = "Nature Reviews Drug Discovery",
issn = "1474-1776",
publisher = "Nature Research",
number = "6",

}

TY - JOUR

T1 - The European Medicines Agency’s goals for regulatory science to 2025

AU - Hines, Philip

AU - Guy, Richard

AU - Humphreys, Anthony

AU - Papaluca-Amati, Marisa

PY - 2019/6/3

Y1 - 2019/6/3

N2 - It is increasingly important that regulatory agencies catalyse the translation of scientific and technological innovation into improved patient-centred health care. Here, we highlight the strategic goals of the European Medicines Agency to advance regulatory science and optimize the opportunities arising in areas such as cell and gene therapies, big data and artificial intelligence.

AB - It is increasingly important that regulatory agencies catalyse the translation of scientific and technological innovation into improved patient-centred health care. Here, we highlight the strategic goals of the European Medicines Agency to advance regulatory science and optimize the opportunities arising in areas such as cell and gene therapies, big data and artificial intelligence.

KW - Drug discovery

UR - http://www.scopus.com/inward/record.url?scp=85066939458&partnerID=8YFLogxK

U2 - 10.1038/d41573-019-00071-2

DO - 10.1038/d41573-019-00071-2

M3 - Comment/debate

VL - 18

SP - 403

EP - 404

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 6

ER -